What is the primary objective of **FDA 21 CFR Part 11**?

**The primary objective of FDA 21 CFR Part 11 is to establish criteria under which the Agency considers electronic records and electronic signatures trustworthy, reliable, and equivalent to paper records and handwritten signatures executed on paper (§11.1(a)).** This equivalency enables electronic technology use while ensuring authenticity, integrity, confidentiality (when appropriate), and non-repudiation through controls like validation (§11.10(a)), access limitation (§11.10(d)), audit trails (§11.10(e)), and signature linking (§11.70).

Who is legally or professionally required to comply with **FDA 21 CFR Part 11**?

**FDA 21 CFR Part 11 applies to organizations using electronic records created, modified, maintained, archived, retrieved, or transmitted under predicate rules, or electronic records/signatures relied upon for regulated activities (§11.1(b)).** Scope includes firms maintaining such records in lieu of paper, submitting accepted electronic records to FDA (docket 92S-0251), or using legally binding electronic signatures. Paper-reliant systems or non-predicate records are generally excluded per 2003 guidance.

Does **FDA 21 CFR Part 11** require an external audit or third-party certification?

**No, FDA 21 CFR Part 11 does not require external audits or third-party certification.** Compliance is demonstrated through internal controls, validation (§11.10(a)), SOPs, training (§11.10(i)), and inspection readiness (§11.1(e)), with systems and documentation available for FDA review. FDA exercises enforcement discretion on some elements but enforces predicate rules and core controls like access and signatures.

How often should an assessment for **FDA 21 CFR Part 11** be performed?

**FDA 21 CFR Part 11 does not prescribe a fixed frequency for assessments; they must occur via change control, periodic reviews, and risk-based validation lifecycle to ensure ongoing fitness for use.** Per 2003 guidance and GAMP practices, reassess scope upon system changes, predicate rule updates, or operational shifts; conduct periodic reviews (e.g., annually) for audit trails, access, and training (§11.10(k)).

What are the consequences of non-compliance with **FDA 21 CFR Part 11**?

**Non-compliance with FDA 21 CFR Part 11 can result in FDA enforcement actions including Form 483 observations, warning letters, product holds, import alerts, or injunctions, as predicate rules remain fully enforceable.** 2003 guidance notes continued enforcement of access controls (§11.10(d)), checks (§11.10(f)-(h)), training (§11.10(i)), signatures (§§11.100-11.300)), with data integrity failures leading to CAPA inadequacies and recalls.

Can **FDA 21 CFR Part 11** be mapped to other international frameworks?

**Yes, FDA 21 CFR Part 11 controls such as audit trails, access limitation, and electronic signatures can be mapped to frameworks like EU Annex 11, though Part 11 stands alone with its narrow scope and enforcement discretion per 2003 guidance.** Common alignments include validation, data integrity (ALCOA+), and open system encryption (§11.30), but mappings require risk-based justification tied to predicate rules.

What is the first step to begin implementing **FDA 21 CFR Part 11**?

**The first step to implement FDA 21 CFR Part 11 is to establish a formal applicability framework mapping predicate rules to records and assessing business reliance on electronic versions (per 2003 guidance).** Document scope decisions in SOPs (e.g., electronic in lieu of paper?); classify systems as closed (§11.3(b)(4)) or open (§11.3(b)(9)); prioritize non-discretionary controls like access (§11.10(d)) and signatures.

What is the primary objective of **ISO 22301**?

**ISO 22301 specifies requirements for establishing, implementing, maintaining, and continually improving a Business Continuity Management System (BCMS).** It enables organizations to protect against, reduce the likelihood of, and ensure recovery from disruptive incidents, maintaining critical products and services via a PDCA (Plan-Do-Check-Act) cycle across 10 clauses.

Who is legally or professionally required to comply with **ISO 22301**?

**ISO 22301 applies to organizations of all sizes and sectors seeking resilience, with heightened professional relevance in critical sectors like utilities, transport, health, finance, and IT.** No universal legal mandate exists, but it supports regulatory compliance (e.g., EU NIS Directive for essential services) and is essential for certified entities demonstrating stakeholder trust and procurement advantages.

Does **ISO 22301** require an external audit or third-party certification?

**ISO 22301 certification requires a two-stage external audit by an accredited body, valid for 3 years with annual surveillance audits.** Stage 1 assesses readiness; Stage 2 verifies effectiveness, typically taking 6-8 weeks, ensuring auditable evidence of clauses 4-10 implementation.

How often should an assessment for **ISO 22301** be performed?

**ISO 22301 mandates annual internal audits and management reviews, plus periodic testing of BCMS processes like BIA and recovery strategies.** Certification involves annual surveillance, with full recertification every 3 years; the standard undergoes systematic review every 5 years, as seen in its 2024 Amendment 1.

What are the consequences of non-compliance with **ISO 22301**?

**Non-compliance with ISO 22301 exposes organizations to unmitigated disruptions, financial losses, reputational damage, and regulatory penalties in mandated sectors.** Certified organizations avoid these via tested BCMS, but lapses in PDCA (e.g., untested plans) risk failures, as 1 in 5 firms face significant annual disruptions without resilience.

Can **ISO 22301** be mapped to other international frameworks?

**Yes, ISO 22301 seamlessly maps to frameworks sharing Annex SL high-level structure, such as ISO 27001 and ISO 31000.** Its PDCA aligns with NIST Cybersecurity Framework's respond/recover functions and supports integrated management systems (IMS) for holistic resilience.

What is the first step to begin implementing **ISO 22301**?

**The first step in ISO 22301 implementation is conducting a gap analysis of organizational context per Clause 4, identifying internal/external issues and interested parties.** This informs BCMS scope, leadership commitment (Clause 5), and BIA/risk assessment (Clause 6), often via tools for a 60-day rollout.

FDA 21 CFR Part 11 vs ISO 22301

Standards Comparison

FDA 21 CFR Part 11

Mandatory

1997

FDA regulation for electronic records and signatures equivalency

ISO 22301

Voluntary

2019

International standard for business continuity management systems

Quick Verdict

FDA 21 CFR Part 11 mandates electronic records/signatures equivalence for US life sciences, ensuring data integrity via validation. ISO 22301 provides voluntary BCMS framework globally for resilience against disruptions. Companies adopt Part 11 for FDA compliance, 22301 for operational continuity.

Electronic Records

FDA 21 CFR Part 11

21 CFR Part 11: Electronic Records; Electronic Signatures

Cost

€€€€

Complexity

Medium

Implementation Time

12-18 months

Key Features

Establishes equivalency criteria for electronic records to paper
Mandates secure time-stamped audit trails for actions
Requires unique non-repudiable electronic signatures
Defines distinct controls for closed and open systems
Enforces risk-based validation and access controls

Business Continuity

ISO 22301

ISO 22301:2019 Business continuity management systems Requirements

Cost

€€€

Complexity

Medium

Implementation Time

0-6 months

Key Features

PDCA cycle for continual BCMS improvement
Business Impact Analysis (BIA) and risk assessment
Leadership commitment and policy requirements
Operational planning with testing and exercises
Seamless integration with ISO 27001 and others

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

FDA 21 CFR Part 11 Details

What It Is

FDA 21 CFR Part 11 is a U.S. regulation defining criteria for electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It targets FDA-regulated industries using electronic systems for predicate-rule records like batch records or submissions. The primary approach is control-based, with narrow scope and risk-based enforcement discretion outlined in the 2003 FDA guidance.

Key Components

**SubpartsGeneral provisions, electronic records (closed/open systems controls), electronic signatures.
Core controls include validation (§11.10(a)), audit trails (§11.10(e)), access limits (§11.10(d)), authority/device checks (§11.10(g)(h)), training (§11.10(i)), and documentation (§11.10(k)).
Signature rules: manifestation (§11.50), linking (§11.70), uniqueness (§11.100), multi-component (§11.200).
Compliance via internal validation, no external certification.

Why Organizations Use It

Mandatory when relying on electronic records for regulated activities.
Ensures data integrity, non-repudiation, and inspection readiness.
Mitigates risks of warnings, holds, recalls.
Drives efficiency in digital transformation and quality systems.
Builds FDA and stakeholder confidence.

Implementation Overview

Risk-based: scope records, classify systems, CSV (IQ/OQ/PQ), SOPs, training.
Phased approach: governance, gap analysis, validation, deployment, monitoring.
Applies to pharma, biotech, devices globally; scales by organization size.
FDA inspections verify compliance.

ISO 22301 Details

What It Is

ISO 22301:2019 is the international standard titled "Security and resilience — Business continuity management systems — Requirements." It is a certifiable framework for establishing, implementing, maintaining, and improving a Business Continuity Management System (BCMS). Its primary purpose is to enhance organizational resilience against disruptions like cyberattacks, pandemics, and natural disasters through a risk-based PDCA (Plan-Do-Check-Act) approach.

Key Components

10 clauses structured around Annex SL high-level structure, with Clauses 4-10 forming the PDCA core.
Key elements: context analysis (Clause 4), leadership commitment (5), BIA and risk assessment (6/8), support resources (7), operations/testing (8), evaluation/audits (9), and improvement (10).
No fixed controls; flexible, tailored requirements.
Certification via accredited bodies: two-stage audits, 3-year validity with annual surveillance.

Why Organizations Use It

Builds resilience, reduces downtime/financial losses, ensures regulatory compliance (e.g., NIS Directive).
Enhances stakeholder trust, reputation, competitive edges like procurement advantages.
Proactive risk management via BIA/RTO, integrates with ISO 27001.

Implementation Overview

Phased approach: gap analysis, BIA, policy development, training, testing, audits.
Applicable to all sizes/sectors; 60 days possible with tools.
Certification in 6-8 weeks post-readiness.

Key Differences

Aspect	FDA 21 CFR Part 11	ISO 22301
Scope	Electronic records/signatures trustworthiness	Business continuity management system resilience
Industry	FDA-regulated life sciences, US-focused	All sectors worldwide, any organization
Nature	Mandatory US regulation, enforced by FDA	Voluntary international certification standard
Testing	Risk-based system validation, audit trails	BIA, exercises, internal/external audits
Penalties	Warning letters, fines, product holds	Loss of certification, no legal penalties

Scope

FDA 21 CFR Part 11

Electronic records/signatures trustworthiness

ISO 22301

Business continuity management system resilience

Industry

FDA 21 CFR Part 11

FDA-regulated life sciences, US-focused

ISO 22301

All sectors worldwide, any organization

Nature

FDA 21 CFR Part 11

Mandatory US regulation, enforced by FDA

ISO 22301

Voluntary international certification standard

Testing

FDA 21 CFR Part 11

Risk-based system validation, audit trails

ISO 22301

BIA, exercises, internal/external audits

Penalties

FDA 21 CFR Part 11

Warning letters, fines, product holds

ISO 22301

Loss of certification, no legal penalties

Frequently Asked Questions

Common questions about FDA 21 CFR Part 11 and ISO 22301

FDA 21 CFR Part 11 FAQ

ISO 22301 FAQ

You Might also be Interested in These Articles...

Top 5 Audit Survival Secrets for Your First SOC 2 Type 2: What Auditors Really Check (and How to Pass)

Master your first SOC 2 Type 2 audit with proven strategies: 40-sample testing, vendor gaps, CPA walkthroughs. Get checklists, scripts & tips from SignWell to s

One Step at a Time - a 6 Month Plan to Live and Breath DORA

Achieve DORA compliance in 6 months with our detailed plan. Learn implementation sequence, starting steps, pitfalls to avoid, and accelerators for success. Toug

You Guide on how to Start Implementing NIST CSF in Your Organization

Master NIST CSF implementation in your organization with this detailed guide. Learn core functions, key steps, best practices, and tips for cybersecurity succes

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Check out these other Gradum.io Standards Comparison Pages

FDA 21 CFR Part 11 vs ISO 14064

Compare FDA 21 CFR Part 11 electronic records rules vs ISO 14064 GHG standards. Uncover validation, audit trails, boundaries & verification diffs for compliance. Expert guide boosts your edge!

EPA vs PDPA

Compare EPA vs PDPA: Decode key differences in compliance, enforcement & strategy for environmental standards vs data protection laws. Boost your regulatory mastery—explore now!

ISO 27018 vs AS9110C

Discover ISO 27018 vs AS9110C: Cloud PII privacy code vs aerospace MRO QMS. Key diffs, controls, benefits for compliance. Secure your ops now!

FDA 21 CFR Part 11

ISO 22301

Quick Verdict

FDA 21 CFR Part 11

Key Features

ISO 22301

Key Features

Detailed Analysis

FDA 21 CFR Part 11 Details

What It Is

Key Components

Why Organizations Use It

Implementation Overview

ISO 22301 Details

What It Is

Key Components

Why Organizations Use It

Implementation Overview

Key Differences

Scope

Industry

Nature

Testing

Penalties

Frequently Asked Questions

FDA 21 CFR Part 11 FAQ

What is the primary objective of FDA 21 CFR Part 11?

Who is legally or professionally required to comply with FDA 21 CFR Part 11?

Does FDA 21 CFR Part 11 require an external audit or third-party certification?

How often should an assessment for FDA 21 CFR Part 11 be performed?

What are the consequences of non-compliance with FDA 21 CFR Part 11?

Can FDA 21 CFR Part 11 be mapped to other international frameworks?

What is the first step to begin implementing FDA 21 CFR Part 11?

ISO 22301 FAQ

What is the primary objective of ISO 22301?

Who is legally or professionally required to comply with ISO 22301?

Does ISO 22301 require an external audit or third-party certification?

How often should an assessment for ISO 22301 be performed?

What are the consequences of non-compliance with ISO 22301?

Can ISO 22301 be mapped to other international frameworks?

What is the first step to begin implementing ISO 22301?

You Might also be Interested in These Articles...

Top 5 Audit Survival Secrets for Your First SOC 2 Type 2: What Auditors Really Check (and How to Pass)

One Step at a Time - a 6 Month Plan to Live and Breath DORA

You Guide on how to Start Implementing NIST CSF in Your Organization

Run Maturity Assessments with GRADUM

Check out these other Gradum.io Standards Comparison Pages

FDA 21 CFR Part 11 vs ISO 14064

EPA vs PDPA

ISO 27018 vs AS9110C